Clearance of beta-amyloid and tau aggregates is size dependent and altered by an inflammatory challenge

2024

Inflammation Affects Beta-Amyloid and Tau Aggregates in Alzheimer's Disease

Sample size: 7 publication 10 minutes Evidence: moderate

Author Information

Author(s): Fertan Emre, Hung Christy, Danial John S H, Lam Jeff Y L, Preman Pranav, Albertini Giulia, English Elizabeth A, Böken Dorothea, Livesey Frederick J, De Strooper Bart, Patani Rickie, Klenerman David

Primary Institution: University of Cambridge

Hypothesis

The study investigates how inflammation alters the clearance of beta-amyloid and tau aggregates in neurons related to Alzheimer's disease.

Conclusion

The study found that inflammation can initiate Alzheimer's disease-like pathology and that the clearance of aggregates is size dependent.

Supporting Evidence

Inflammation can worsen Alzheimer's disease pathology in neurons.
Smaller aggregates are cleared more effectively than larger ones.
Chronic inflammation alters the production and clearance of beta-amyloid and tau aggregates.
PSEN1 mutation leads to increased intracellular tau aggregation.
Aggregate size impacts the ability of neurons to clear them.
Human brain samples showed similar size-dependent clearance mechanisms.
Different cytokines may have varying effects on Alzheimer's disease pathology.

Takeaway

This study shows that inflammation can make Alzheimer's disease worse by causing more harmful proteins to build up in brain cells, and that smaller proteins can be cleared out more easily than larger ones.

Methodology

The study used single-molecule detection and super-resolution imaging techniques to analyze beta-amyloid and tau aggregates in human-induced pluripotent stem cell-derived cortical neurons.